Release Date: 25/02/16 17:00 Summary: Change in substantial holding - J.P. Morgan Price Sensitive: No Download Document 1.62MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%